Constitutively active PI3K catalytic subunit alpha (PIK3CA) interfered with apoptosis induction downstream of death rece...
...PIK3CA for predicting the response to anti-EGFR therapies, a common drug used for CRC treatment; 4) patents on epigeneti...
...PIK3CA and pAkt expression, with substantial proportions being PIK3CA⁻/pAkt⁺ or PIK3CA⁺/pAkt⁻. These four combinatorial ...
...PIK3CA, AKT1 and other related genes. There was no difference in age, gender, tumor size and angioinvasion between encap...
...PIK3CA and PTEN occur at a relatively low frequency in haematological malignancies, activation of PI3K signalling is oft...
...PIK3CA. This paralleled the frequent activation of AKT and MAPK pathways. In particular, activation of the MAPK pathway ...
...PIK3CA and AKT1 mutations. PIK3CA hotspot mutations were analysed using a highly sensitive SNaPshot assay, and exon 4 of...
...PIK3CA mutations identified in human cancers. I also discuss the association of PIK3CA mutations with other genetic mark...
The involvement of the PIK3CA gene product p110α, the catalytic subunit of phosphatidylinositol 3-kinase (PI3K), in huma...
...PIK3CA gene that is based on a combination of PCR and HRMA. The PIK3CA HRMA assay was evaluated by performing repeatabil...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
